Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed May 20, 2022
- Accession no.
- 0001209191-22-031172
- Filed
- May 20, 2022
- Trade date
- May 18-19, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $198.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | Common Stock | MOption exerciseAcquired | +2,642 | – | – | 8,125,445 | Direct | |
| May 18, 2022 | Common Stock | FTax withholdingDisposed | −1,030 | $9.65 | −$9,939.5 | 8,124,415 | Direct | |
| May 19, 2022 | Common Stock | SSaleDisposed | −20,000 | $9.92 | −$198,400 | 8,104,415 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | Common Stock | MOption exerciseDisposed | −2,642 | $0.00 | $0 | 29,066 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.